Advertisement
Screener

PROCEPT BioRobotics Corporation (PRCT) Current Foreign Tax Expense (Benefit)

2.8 / 5 stars · 68/120 Roast Me

PROCEPT BioRobotics Corporation Current Foreign Tax Expense (Benefit)

PROCEPT BioRobotics Corporation (PRCT) reported Current Foreign Tax Expense (Benefit) of $190.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2026-02-26

  • PROCEPT BioRobotics Corporation current foreign tax expense (benefit) for fiscal 2025 was $190.00K, a 48.37% decline from fiscal 2024.
  • PROCEPT BioRobotics Corporation current foreign tax expense (benefit) for fiscal 2024 was $368.00K, a 360.00% increase from fiscal 2023.
  • PROCEPT BioRobotics Corporation current foreign tax expense (benefit) for fiscal 2023 was $80.00K.
Period endCurrent Foreign Tax Expense (Benefit) 12 month
2025-12-31$190.00K
10-K · filed 2026-02-26
2024-12-31$368.00K
10-K · filed 2026-02-26
2023-12-31$80.00K
10-K · filed 2026-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
SpyGlass Pharma, Inc. (SGP)United States$0.925B
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B